Used in research and development for studying the adenosine A2A receptor (A2AR) signaling pathways, this antibody serves as a critical tool in immunoprecipitation, flow cytometry, and receptor binding assays. It enables precise detection and quantification of A2AR expression in immune cells and cancer tissues, supporting investigations in immuno-oncology and neurodegenerative diseases. Due to its high specificity, it is employed in validating target engagement of A2AR-targeted therapeutics and in mechanistic studies of immune suppression within the tumor microenvironment.